Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years.
Kojima R, Kami M, Kanda Y, Kusumi E, Kishi Y, Tanaka Y, Yoshioka S, Morishima S, Fujisawa S, Mori SI, Kasai M, Hatanaka K, Tajima K, Kasai M, Mitani K, Ichinohe T, Hirai H, Taniguchi S, Sakamaki H, Harada M, Takaue Y.
Kojima R, et al. Among authors: sakamaki h.
Bone Marrow Transplant. 2005 Oct;36(8):667-74. doi: 10.1038/sj.bmt.1705122.
Bone Marrow Transplant. 2005.
PMID: 16113674